Matches in Wikidata for { <http://www.wikidata.org/entity/Q73435281> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q73435281 description "artículu científicu espublizáu en xunu de 1997" @default.
- Q73435281 description "im Juni 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73435281 description "scientific article published on 01 June 1997" @default.
- Q73435281 description "wetenschappelijk artikel" @default.
- Q73435281 description "наукова стаття, опублікована в червні 1997" @default.
- Q73435281 name "Non-peptide glycoprotein IIb/IIIa inhibitors. 17. Design and synthesis of orally active, long-acting non-peptide fibrinogen receptor antagonists" @default.
- Q73435281 name "Non-peptide glycoprotein IIb/IIIa inhibitors. 17. Design and synthesis of orally active, long-acting non-peptide fibrinogen receptor antagonists" @default.
- Q73435281 type Item @default.
- Q73435281 label "Non-peptide glycoprotein IIb/IIIa inhibitors. 17. Design and synthesis of orally active, long-acting non-peptide fibrinogen receptor antagonists" @default.
- Q73435281 label "Non-peptide glycoprotein IIb/IIIa inhibitors. 17. Design and synthesis of orally active, long-acting non-peptide fibrinogen receptor antagonists" @default.
- Q73435281 prefLabel "Non-peptide glycoprotein IIb/IIIa inhibitors. 17. Design and synthesis of orally active, long-acting non-peptide fibrinogen receptor antagonists" @default.
- Q73435281 prefLabel "Non-peptide glycoprotein IIb/IIIa inhibitors. 17. Design and synthesis of orally active, long-acting non-peptide fibrinogen receptor antagonists" @default.
- Q73435281 P1433 Q73435281-C373481C-32C6-454A-BE49-00E6CD141126 @default.
- Q73435281 P1476 Q73435281-B235E6E7-B1A7-45FF-9E00-15EE2126DFBE @default.
- Q73435281 P2093 Q73435281-1393F111-F2A2-4921-B62C-D86F794E6465 @default.
- Q73435281 P2093 Q73435281-14863913-C014-4EEA-A780-1C5D98CD8077 @default.
- Q73435281 P2093 Q73435281-185E31CF-A766-43A7-A5D7-F28071118F5D @default.
- Q73435281 P2093 Q73435281-1A8BE57A-224E-407C-8CAB-3B6A220A3E63 @default.
- Q73435281 P2093 Q73435281-29674BD9-1E39-4612-A12F-3AC7B245CE75 @default.
- Q73435281 P2093 Q73435281-504E9A81-1BC4-4D1A-89BD-55D6E91D63EE @default.
- Q73435281 P2093 Q73435281-5254AB7D-45E4-4F3B-A4ED-072F04757CEA @default.
- Q73435281 P2093 Q73435281-55FF36B1-8CD8-410F-B003-9A0148B69842 @default.
- Q73435281 P2093 Q73435281-5E24BF28-F756-4763-8AA7-EA97BA1517ED @default.
- Q73435281 P2093 Q73435281-7B94D56B-CCF6-4705-B727-43E60BD8D328 @default.
- Q73435281 P2093 Q73435281-84C68DA0-7687-4106-B72D-E16ECBE6559C @default.
- Q73435281 P2093 Q73435281-8ED89E33-8012-4796-A4A9-3F7FE3630B67 @default.
- Q73435281 P2093 Q73435281-91842384-44FD-4CE7-97B4-7E4F41FF99F8 @default.
- Q73435281 P2093 Q73435281-A09755AE-B3D4-4006-B6EF-5C7C8BB29B88 @default.
- Q73435281 P2093 Q73435281-C182C561-A933-4AA3-A741-4F2A52182615 @default.
- Q73435281 P2093 Q73435281-C1F44C96-7BE7-49CB-BDF3-85BF5A56FD38 @default.
- Q73435281 P2093 Q73435281-C2FDA295-1F31-492D-913B-BF11122BC0EF @default.
- Q73435281 P2093 Q73435281-E06470BB-9E4B-4EA4-8C4C-D653AA645F0B @default.
- Q73435281 P2093 Q73435281-EA18EB31-8374-4802-BEB4-D79D664FB8FB @default.
- Q73435281 P2093 Q73435281-FE6AC1D4-0333-466E-A2A3-069EA56AE94F @default.
- Q73435281 P304 Q73435281-DF58C67B-81B6-41F3-A1A4-9BDE71CBDB76 @default.
- Q73435281 P31 Q73435281-3B36207F-7471-4F6E-B366-A358F245F571 @default.
- Q73435281 P356 Q73435281-63DBF521-F1FC-4A86-AEE0-EFBF7451E8C0 @default.
- Q73435281 P407 Q73435281-9F5633AE-F3A7-4F28-BBF5-3279961D4A53 @default.
- Q73435281 P433 Q73435281-ABF3A383-8D59-43F0-88CC-25AD3131503E @default.
- Q73435281 P478 Q73435281-03D4E16F-8466-4609-8A1E-5FDC0743FA98 @default.
- Q73435281 P577 Q73435281-DCC46526-BF8A-463E-BCA3-483C8388075A @default.
- Q73435281 P698 Q73435281-1FBD9065-2D8F-47C7-BD8F-6815D50EB155 @default.
- Q73435281 P356 JM9608117 @default.
- Q73435281 P698 9191954 @default.
- Q73435281 P1433 Q900316 @default.
- Q73435281 P1476 "Non-peptide glycoprotein IIb/IIIa inhibitors. 17. Design and synthesis of orally active, long-acting non-peptide fibrinogen receptor antagonists" @default.
- Q73435281 P2093 "Askew BC" @default.
- Q73435281 P2093 "Baldwin JJ" @default.
- Q73435281 P2093 "Bednar B" @default.
- Q73435281 P2093 "Bednar RA" @default.
- Q73435281 P2093 "Claremon DA" @default.
- Q73435281 P2093 "Cook JJ" @default.
- Q73435281 P2093 "Gaul SL" @default.
- Q73435281 P2093 "Glass JD" @default.
- Q73435281 P2093 "Gorham LM" @default.
- Q73435281 P2093 "Gould RJ" @default.
- Q73435281 P2093 "Hamill T" @default.
- Q73435281 P2093 "Hartman GD" @default.
- Q73435281 P2093 "Holahan MA" @default.
- Q73435281 P2093 "Hunt CA" @default.
- Q73435281 P2093 "Lynch JJ Jr" @default.
- Q73435281 P2093 "Lynch RJ" @default.
- Q73435281 P2093 "McIntyre CJ" @default.
- Q73435281 P2093 "Prueksaritanont T" @default.
- Q73435281 P2093 "Sitko GR" @default.
- Q73435281 P2093 "Stranieri MT" @default.
- Q73435281 P304 "1779-1788" @default.
- Q73435281 P31 Q13442814 @default.
- Q73435281 P356 "10.1021/JM9608117" @default.
- Q73435281 P407 Q1860 @default.
- Q73435281 P433 "12" @default.
- Q73435281 P478 "40" @default.
- Q73435281 P577 "1997-06-01T00:00:00Z" @default.
- Q73435281 P698 "9191954" @default.